Viridian Therapeutics, Inc.\DE (VRDN) Other Operating Expenses (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$672000.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 1766.67% year-over-year to -$672000.0; the TTM figure through Mar 2026 stood at -$2.3 million (down 379.47% YoY), while the FY2025 annual figure was -$1.7 million, down 427.71% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$672000.0, up from -$2.1 million in the prior quarter.
• The five-year high for Other Operating Expenses was $33.7 million in Q4 2022, with the low at -$2.1 million in Q4 2025.
• The 4-year median for Other Operating Expenses is -$195000.0 (2024), against an average of $4.4 million.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses surged 332.31% in 2025, then tumbled 1766.67% in 2026.
• Viridian Therapeutics, Inc.\DE's Other Operating Expenses stood at $33.7 million in 2022, then plunged by 100.76% to -$256000.0 in 2024, then sank by 726.56% to -$2.1 million in 2025, then jumped by 68.24% to -$672000.0 in 2026.
• Business Quant data shows VRDN's Other Operating Expenses at -$672000.0 in Q1 2026, -$2.1 million in Q4 2025, and $453000.0 in Q3 2025.